» Articles » PMID: 33185871

In Vitro Physical and Functional Interaction Assays to Examine the Binding of Progranulin Derivative Atsttrin to TNFR2 and Its Anti-TNFα Activity

Overview
Specialty Molecular Biology
Date 2020 Nov 13
PMID 33185871
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

TNFα/TNFR signaling plays a critical role in the pathogenesis of various inflammatory and autoimmune diseases, and anti-TNFα therapies have been accepted as the effective approaches for treating several autoimmune diseases. Progranulin (PGRN), a multi-faced growth factor-like molecule, directly binds to TNFR1 and TNFR2, particularly to the latter with higher affinity than TNFα. PGRN derivative Atsttrin is composed of three TNFR-binding domain of PGRN and exhibits even better therapeutic effects than PGRN in several inflammatory disease models, including collagen-induced arthritis. Herein we describe the detailed methodology of using (1) ELISA-based solid phase protein-protein interaction assay to demonstrate the direct binding of Atsttrin to TNFR2 and its inhibition of TNFα/TNFR2 interaction; and (2) tartrate-resistant acid phosphatase (TRAP) staining of in vitro osteoclastogenesis to reveal the cell-based anti-TNFα activity of Atsttrin. Using the protocol described here, the investigators should be able to reproducibly detect the physical inhibition of TNFα binding to TNFR and the functional inhibition of TNFα activity by Atsttrin and various kinds of TNF inhibitors.

Citing Articles

Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases.

Zhou R, Hu W, Ma P, Liu C Bone Res. 2024; 12(1):58.

PMID: 39406741 PMC: 11480210. DOI: 10.1038/s41413-024-00370-4.


Atsttrin regulates osteoblastogenesis and osteoclastogenesis through the TNFR pathway.

Liu K, Wang Z, Liu J, Zhao W, Qiao F, He Q Commun Biol. 2023; 6(1):1251.

PMID: 38081906 PMC: 10713527. DOI: 10.1038/s42003-023-05635-y.


Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.

Huang G, Jian J, Liu C Cytokine Growth Factor Rev. 2023; 76:142-159.

PMID: 37981505 PMC: 10978308. DOI: 10.1016/j.cytogfr.2023.11.001.


Injectable hydrogel for sustained delivery of progranulin derivative Atsttrin in treating diabetic fracture healing.

Moradi L, Witek L, Nayak V, Pereira A, Kim E, Good J Biomaterials. 2023; 301:122289.

PMID: 37639975 PMC: 11232488. DOI: 10.1016/j.biomaterials.2023.122289.


Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition.

Diaz M, Mestres-Arenas A, Lerin C, Cereijo R, Lopez-Bermejo A, de Zegher F Pediatr Res. 2023; 94(3):1189-1194.

PMID: 37031297 DOI: 10.1038/s41390-023-02595-1.

References
1.
Jules J, Feng X . In vitro investigation of the roles of the proinflammatory cytokines tumor necrosis factor-α and interleukin-1 in murine osteoclastogenesis. Methods Mol Biol. 2014; 1155:109-23. DOI: 10.1007/978-1-4939-0669-7_10. View

2.
Tian Q, Zhao Y, Mundra J, Gonzalez-Gugel E, Jian J, Uddin S . Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity. Front Biosci (Landmark Ed). 2014; 19(7):1176-85. PMC: 4410860. DOI: 10.2741/4274. View

3.
Faustman D . TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment. Diabetes Metab Res Rev. 2017; 34(1). DOI: 10.1002/dmrr.2941. View

4.
Chen G, Goeddel D . TNF-R1 signaling: a beautiful pathway. Science. 2002; 296(5573):1634-5. DOI: 10.1126/science.1071924. View

5.
Vezina A, Vaillancourt-Jean E, Albarao S, Annabi B . Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-α and requires NF-κB signaling. Cancer Lett. 2013; 345(1):100-5. DOI: 10.1016/j.canlet.2013.11.021. View